Tata Consultancy Services Ltd. Share Price

Overview

Tata Consultancy Services Ltd. share price is currently ₹2,260.31, up by ₹20.26 (0.9%) from its previous closing price of ₹2,240.05. The share price has gained 4.24% over the past month and declined -22.45% over the past year. The stock's 52-week low and high are ₹1,959.70 and ₹3,323.70, respectively. Tata Consultancy Services Ltd. has a market capitalisation of ₹ 7,80,000.00 Cr. The share price was last updated on 14 Oct 2026, 03:59 PM IST.

Tata Consultancy Services Ltd.
Tata Consultancy Services Ltd.
TCS
 ₹0.00
 ₹20.26
0.90%
IT
 ₹0.00(%)1D

Updated: 14 Oct 2026, 03:59:58 pm IST

Market Data

Open Price

 ₹2,260.43

Prev. Close

 ₹2,240.05
 ₹2,251.85

Day Low

 ₹2,262.56

Day High

 ₹1,959.70

52 Week Low

 ₹3,323.70

52 Week High

ITIT - Software
CategoryLarge Cap

Fundamentals

Quick Bite

Price To Earnings Ratio

15.86

Sector PE

19.51

PB Ratio

7.62

Sector PB

4.49

EPS

142.56

Dividend Yield

4.66

Today's Volume

12.522 M

5 Day Avg. Volume

8.940 M

PEG Ratio

11.75

Market Cap.

₹ 7,80,000.00 Cr.

StockGro Trade views

Technical Analysis

Forecasts 🧭

Financials

Corporate Actions

ActionsEx-DateRecord-Date
DividendsInterim Dividend of 1200% at ₹12/Share
14-Oct-202614-Oct-2026
DividendsInterim Dividend of 1200% at ₹12/Share
15-Jul-202615-Jul-2026
DividendsFinal Dividend of 3100% at ₹31/Share
25-May-202625-May-2026
DividendsInterim Dividend of 1100% at ₹11/Share
16-Jan-202617-Jan-2026

Mutual Fund Ownership

Mutual Fund Holder
Aug 26
Shares held
Sep 26
Shares held
SBI Nifty 50 ETF1.98 Cr
1.98 Cr
(0.01%)
Parag Parikh Flexi Cap Fund - Regular Plan - Growth1.77 Cr
1.77 Cr
no change
SBI BSE Sensex ETF1.35 Cr
1.36 Cr
(0.5%)
Nippon India Large Cap Fund - Growth80.00 Lac
78.00 Lac
(2.5%)
ICICI Prudential Value Fund - Growth72.01 Lac
72.01 Lac
no change

About Tata Consultancy Services Ltd. 👋

Tata Consultancy Services Ltd is an India-based company. The Company is engaged in providing information technology (IT) services, consulting, and business solutions. Its business segments include Banking, Financial Services and Insurance; Manufacturing; Consumer Business; Communication, Media and Technology; Life Sciences and Healthcare and Others such as Energy, Resources and Utilities, s-Governance and Products. The Company's products include TCS ADD, TCS BaNCS, TCS BFSI Platforms, TCS CHROMA, TCS Customer Intelligence & Insights, TCS ERP on Cloud, TCS Intelligent Urban Exchange, Quartz-The Smart Ledgers, TCS Optumera, TCS TwinX, TCS TAP, TCS OmniStore, TCS MasterCraft, Jile, and others. Its services consist of Artificial Intelligence and Data & Analytics, Cloud, Cognitive Business Operations, Consulting, Cybersecurity, Enterprise Solutions, Industrial Autonomy and Engineering, and Network Solutions and Services, TCS Interactive, and others.

Expert Opinions

Insights from SEBI-registered analysts · updated live

Explore all →
Mohammed Shoaib

Mohammed Shoaib

14 Oct • 7:59 PM · SEBI-Registered Analyst

TCS Wins Banking Technology Contract: Why This Matters

Tata Consultancy Services

TCS
is in focus after securing a contract from Australia's MyState to implement its TCS BaNCS Global Banking Platform. Why this development matters Banking technology contracts can provide long-term opportunities for IT service providers. Core banking modernisation can help financial institutions streamline operations and build systems that support future expansion. However, the commercial impact depends on the contract's scope, implementation schedule and revenue recognition. A new deal does not automatically translate into an immediate earnings boost. What I would monitor 1. Deal conversion: How quickly does the contract move from implementation to revenue contribution? 2. Banking demand: Are financial institutions continuing to invest in technology upgrades? 3. Margins: Can TCS deliver new projects without putting pressure on profitability? 4. Valuation: Does the current share price adequately reflect expected growth? My view The contract is a constructive business development, but investors should assess it alongside TCS's overall deal pipeline, quarterly growth and operating margins. Consistent execution matters more than the headline announcement.

See More
Manjushri Sharma SEBI RA

Manjushri Sharma SEBI RA

14 Oct • 7:50 PM · SEBI-Registered Analyst

Indian IT Stocks Rally While Oil Prices Weigh on Sentiment

TCS
Indian equity markets traded with limited gains on Wednesday after the previous session's strong rally. The Nifty 50 was up approximately 0.07% at 22 738.05 in early trading while the Sensex gained around 0.13% to 73 128.50. Information technology stocks continued to attract buying interest following encouraging quarterly earnings particularly from major IT companies. However the recovery remained vulnerable to external pressures. Crude oil prices climbed toward $107 per barrel amid geopolitical concerns raising worries about India's import bill inflation and corporate input costs. Continued foreign portfolio investor selling also weighed on sentiment while investors assessed the sustainability of the previous session's gains. Market participants are likely to monitor quarterly earnings crude oil movements foreign fund flows and global market trends for further direction. The Nifty's ability to sustain its recovery will be important in determining whether the latest rebound develops into a broader trend. Important Disclaimer: This article is for informational and educational purposes only and does not constitute investment advice or a recommendation to buy or sell securities. Investors should conduct independent research before making investment decisions. Securities investments are subject to market risks.

See More
ArthavrkshRA

ArthavrkshRA

14 Oct • 7:38 PM · SEBI-Registered Analyst

Nifty IT Reclaims 30,100 After Double Hammer

Nifty IT is up 5.59% for the week so far, trading near 30,171 and back above the 30,100 level, which had acted as resistance. The weekly chart shows how this came about. Two consecutive hammer-type candles with long lower shadows formed around the 28,300 zone, a level that has switched between resistance and support and sits close to the lower rising trendline. Buyers stepped in at that support, and this week’s strong candle follows. The move has also been broad. Several IT names, including

TCS
, LTIMindtree, Intellect Design and Tata Elxsi, have gained roughly 6-15% in just three sessions, which suggests interest at lower levels. Levels: resistance at 31,290, then 32,130. Support at 30,100, then 28,300. RSI at 51.15 has moved just above the midline. The 50-week average (31,933) and 200-week average (34,405) still sit above price, and the earlier death cross keeps the larger trend in view. Hammer candles near a tested support show buyers stepping in, and a move above resistance adds weight, but longer-term averages still frame the bigger picture. Disclaimer:This is for educational purposes only and is not investment advice. Please consult your financial advisor before making any investment decisions. SEBI Registered Research Analyst — INH000025212.

See More
Hemraj Singh Sikarwar

Hemraj Singh Sikarwar

14 Oct • 2:52 PM · SEBI-Registered Analyst

Infosys: Is the IT Sector Finally Finding Its Footing?

Indian IT stocks are showing relative strength while the broader market remains cautious. On October 14, buying interest in Infosys, TCS and !HCLTECH helped limit the downside in benchmark indices. But does a sector rebound automatically mean a fresh uptrend? Not necessarily. Here are three factors I would track in Infosys: 1. Client spending Demand from banking, retail and other large international clients will influence the pace of new technology contracts. 2. Artificial intelligence AI-related services could create new revenue opportunities, but investors also need to assess pricing pressure and the impact on traditional IT services. 3. Guidance and margins Management's revenue outlook, operating margins and deal conversion will be more important than a single session of share-price strength. My view The recent recovery in IT stocks is encouraging, but confirmation should come from earnings and sustained buying participation. I would avoid assuming that the sector has entered a durable uptrend simply because prices have rebounded. The next question is whether Infosys can demonstrate improving demand and earnings visibility through the current results season.

See More
Shrikant Pandey

Shrikant Pandey

14 Oct • 12:13 PM · SEBI-Registered Analyst

TCS: Selected by MyState Limited for Core Banking

TCS: Selected by MyState Limited for Core Banking Transformation

TCS
MyState Limited has selected TCS BaNCS Global Banking Platform to transform and consolidate its core banking operations. The deployment will support the unified banking platform following the merger of MyState Bank and Auswide Bank. TCS BaNCS will consolidate multiple banking systems, business processes, data repositories and customer-servicing platforms into a single operating model. The platform leverages model-bank architecture, configurable products, workflow automation, API-led integration and AI-based transformation tools. The scalable platform is expected to support post-merger integration, improve operational efficiency and enable potential future acquisitions. Impact: Positive — The win strengthens TCS BaNCS' presence in the Australian banking market and reinforces TCS' positioning in large-scale core banking transformation and post-merger consolidation.

See More
DEEPAK PAL

DEEPAK PAL

14 Oct • 11:55 AM · SEBI-Registered Analyst

SECTOR CORNER---> KNOW WHICH SECTORS ARE IN NEWS & EVENTS !

Healthcare Faces Regulatory Pressure; EV Theme Puts Auto Stocks in Focus Two sectors are attracting investors’ attention today: Healthcare, amid Supreme Court scrutiny of medicine pricing, and Automobiles, as Nomura highlights opportunities linked to rising EV adoption. IT stocks are also in focus following the recent earnings-led rally. 1. HEALTHCARE & HOSPITALS: REGULATORY UNCERTAINTY RISES Morgan Stanley’s View on Indian Healthcare The Supreme Court has questioned why medicine price controls are limited to cancer drugs and why manufacturers can set prices for several other medicines and medical products. --->Stocks to Watch

APOLLOHOSP
Max Healthcare Fortis Healthcare Aster DM Healthcare Dr. Lal PathLabs Market impact: Hospital stocks may remain sensitive to developments around medicine pricing, particularly if investors expect tighter controls on pharmacy-related margins. Pharmaceutical companies could also face uncertainty if price regulation expands beyond oncology. 2. AUTOMOBILES & EVs: NOMURA FAVOURS EV-EXPOSED COMPANIES Nomura’s Preferred Auto Picks Nomura believes companies with competitive electric-vehicle products, established technology and greater EV exposure could outperform the broader automobile industry in the second half of FY27 and FY28. --->Stock View Ather Energy BUY Mahindra & Mahindra BUY Hyundai Motor India BUY Tata Motors Passenger Vehicles NEUTRAL Sona BLW Precision Forgings BUY Exide Industries BUY 3. INFORMATION TECHNOLOGY: EARNINGS-LED MOMENTUM CONTINUES Tata Elxsi also attracted attention after reporting a year-on-year increase in September-quarter profit. However, Morgan Stanley and Motilal Oswal maintained cautious views on the stock, highlighting the importance of looking beyond the immediate earnings reaction. Stocks to Watch HCLTech Tata Elxsi Tech Mahindra TCS Wipro

See More

News & Events

Frequently Asked Questions

What is the share price of Tata Consultancy Services Ltd.?

What is the market cap of Tata Consultancy Services Ltd.?

Should I buy Tata Consultancy Services Ltd. stock now?

What is the 52 week high and low of Tata Consultancy Services Ltd.?

Is the Tata Consultancy Services Ltd. stock good to buy?

Is Tata Consultancy Services Ltd. a good buy for the long term?

Is Tata Consultancy Services Ltd. overvalued or undervalued?

What is the PE and PB ratio of Tata Consultancy Services Ltd.?

Start Now